(2025). Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR Morbidity and Mortality Weekly Report.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025."
MMWR Morbidity and Mortality Weekly Report 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025."
MMWR Morbidity and Mortality Weekly Report, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.